Upload File

acorda therapeutics v. actavis laboratories fl et. al

  • Home
  • Documents
  • Acorda Therapeutics v. Actavis Laboratories FL et. al
17

Upload: priorsmart

Post on 21-Jul-2016

43 views

Category:

Documents


0 download

Report

DESCRIPTION

Official Complaint for Patent Infringement in Civil Action No. 1:14-cv-00882-UNA: Acorda Therapeutics Inc. v. Actavis Laboratories FL Inc. et. al. Filed in U.S. District Court for the District of Delaware, no judge yet assigned. See http://news.priorsmart.com/-laFe for more info.

TRANSCRIPT

Page 1: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 2: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 3: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 4: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 5: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 6: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 7: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 8: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 9: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 10: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 11: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 12: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 13: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 14: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 15: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 16: Acorda Therapeutics v. Actavis Laboratories FL et. al
Page 17: Acorda Therapeutics v. Actavis Laboratories FL et. al

Watson and Actavis Synergy

Texas AG - Actavis Settlement Agreement

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · 1. NAME OF THE MEDICINAL PRODUCT . Imatinib Actavis 50 mg hard capsules . Imatinib Actavis 100 mg hard capsules . ... Imatinib Actavis

1 | Preclinical Programs November 2008 Acorda Therapeutics: Preclinical Pipeline March 6, 2009

Learning to be Resilient in the World of MS to be Resilient in the World of MS July 11, 2017 Presented by: Genentech | Novartis | Teva Pharmaceuticals | Acorda Therapeutics | Mallinckrodt

No. 2015-1456 · 2019. 12. 18. · No. 2015-1456 UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT _____ ACORDA THERAPEUTICS INC. and ALKERMES PHARMA IRELAND LIMITED, Plaintiffs-Appellees,

recro vs actavis

United States Court of Appeals for the Federal Circuit · 2 ACORDA THERAPEUTICS INC.v. MYLAN PHARM. INC. Appeal from the United States District Court for the District of Delaware

allergan-web-cdn-prod.azureedge.netallergan-web-cdn-prod.azureedge.net/actavis/actavis/media/allergan-… · Actavis Public Limited Company DIRECTORS AND OTHER INFORMATION Board of

ADMINISTRATIVE ACTAVIS - NYU Law Review

Acorda Therapeutics: Preclinical Pipeline

United States Court of Appeals for the Federal Circuit · 2018. 12. 3. · United States Court of Appeals for the Federal Circuit ACORDA THERAPEUTICS, INC., ... competitors had tried

Kent Rogers, Acorda, New Paradigms 2012

Actavis UK Limited and others (Appellants… · Actavis UK Limited and others (Appellants) v Eli Lilly and Company (Respondent) Eli Lilly and Company ... manufactured by the Actavis

ACORDA THERAPEUTICS, INC.d18rn0p25nwr6d.cloudfront.net/CIK-0001008848/accd8ddb-86...market three U.S. Food and drug Administration (FdA)-approved therapies, including Ampyra (dalfampridine)

Third Circuit appellee brief of Actavis in Endo v Actavis false advertising case July 2014

Actavis/Auden: full text decision

ACORDA THERAPEUTICS, INC.d18rn0p25nwr6d.cloudfront.net/CIK-0001008848/e...network of specialty pharmacies. Our preparations for the commercial sale of Inbrija continue, including sales

DEACTIVATING ACTAVIS THE CLASH BETWEEN THE SUPREME … · 2015] DEACTIVATING ACTAVIS 559 Actavis.6 The drug manufacturers could in effect use patent rights, however weak, as the pretext

ACORDA THERAPEUTICS, INC.s1.q4cdn.com/271808180/files/doc_financials/2016/Acorda-2016-10K.pdf · increase of approximately 13% over 2015. we also market Zanaflex Capsules and tablets,

allergan-web-cdn-prod.azureedge.netallergan-web-cdn-prod.azureedge.net/actavis/actavis/...60 / ! , - . % ! , - . 6, - . 6 % 3 ! / %

Enhance Your Job Search with Online Resources...Enhance Your Job Search with Online Resources April 4, 2017 Presented by: Genentech | Teva Pharmaceuticals | Acorda Therapeutics DirectEmployers

Mind and Body - National Multiple Sclerosis Society€¦ · Mind and Body: A Winning Team in Stress Management May 10, 2016 Presented by: Teva Pharmaceuticals | Acorda Therapeutics

Acorda Therapeutics J.P. Morgan Healthcare Conferences1.q4cdn.com/271808180/files/doc_presentations/2020/FINAL-ACO… · Acorda’slong-term value proposition and 2020 outlook strengthened

Apotex v. Acorda - 2nd Circuit opinon.pdf

A path forward. ACORDA THERAPEUTICS, INC. 2010 ANNUAL …annualreports.co.uk/HostedData/AnnualReportArchive/a/NASDAQ_AC… · in Acorda’s fi rst quarterly profi t in the third

2015 ANNUAL REPORT - s1.q4cdn.coms1.q4cdn.com/.../doc_financials/2015/Acorda-2015-Annual-Report.pdf2015 ANNUAL REPORT. DEAR MEMBERS OF THE ACORDA COMMUNITY: We aim to grow Acorda into

Bass petition at Acorda

ACORDA THERAPEUTICS, INC.s1.q4cdn.com/.../2018/ACORDA-THERAPEUTICS-INC._10K_2018.pdfACORDA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 13-3831168

Acorda Corporate Update

2017 ANNUAL REPORTs1.q4cdn.com › 271808180 › files › ...2017-Annual-Report.pdfThe trademarks in the Acorda Therapeutics, Inc. 2017 Annual Report are owned by Acorda Therapeutics,

No. 18-1280 IN THE Supreme Court of the United States · No. 18-1280 IN THE Supreme Court of the United States _____ ACORDA THERAPEUTICS, INC., Petitioner, v. ROXANE LABORATORIES,

Federal Trade Commission vs Actavis

IN THE UNITED STATES DISTRICT COURT FOR THE … · FOR THE DISTRICT OF DELAWARE ACORDA THERAPEUTICS, INC. and ALKERMES PHARMA IRELAND LIMITED, Plaintiffs ... is one of the largest

Allergan v. Actavis et. al